Patents Assigned to BIOMUNE COMPANY
  • Vaccines against avian reoviruses
    Patent number: 11813321
    Abstract: The present invention relates to vaccine and composition comprising at least one antigenic material derived from an avian reovirus and an adjuvant comprising a lipophile and a polymer of acrylic or methacrylic acid and uses thereof for vaccinating avian against reoviruses.
    Type: Grant
    Filed: July 12, 2019
    Date of Patent: November 14, 2023
    Assignee: BIOMUNE COMPANY
    Inventors: Kristi Mae Dorsey, Brianna Ford, Christopher Luther, John Knox Rosenberger
  • Dual adjuvant vaccine compositions, preparation and uses
    Patent number: 10772954
    Abstract: The present invention relates to vaccines comprising an effective amount of at least one antigen in a water-in-oil-in-water (WOW) emulsion and an additional adjuvant, and to the methods of preparation and uses thereof.
    Type: Grant
    Filed: June 15, 2015
    Date of Patent: September 15, 2020
    Assignee: Biomune Company
    Inventors: Roger H. Ruehling, Brianna Ford
  • Turkey herpesvirus vectored recombinant containing avian influenza genes
    Patent number: 10655146
    Abstract: The present invention provides a recombinant turkey herpesvirus modified by the presence of the cDNA encoding the hemagglutinin protein of avian influenza virus under a promoter. A poultry vaccine comprising the recombinant turkey herpesvirus described in the present invention can induce serological responses that may be easily detected by the hemagglutination inhibition assay but not by commercially available diagnostic ELISA kits; thus enabling easy differentiation between vaccination and field infection.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: May 19, 2020
    Assignee: BIOMUNE COMPANY
    Inventors: Motoyuki Esaki, Lauren Elizabeth Jensen, Kristi M. Dorsey
  • IBV strains and uses thereof
    Patent number: 10190099
    Abstract: The present invention relates to novel infectious bronchitis virus strains and the uses thereof. The invention particularly relates to an inactivated or attenuated IBV, as well as to vaccine compositions comprising the same and the uses thereof to vaccinate avians. The invention also relates to nucleic acids, infected cells and methods for detecting the infectious bronchitis virus strains of the invention in any sample.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: January 29, 2019
    Assignee: BIOMUNE COMPANY
    Inventors: Wil Solano, Brianna Ford, Chris Luther
  • Turkey herpesvirus vectored recombinant containing avian influenza genes
    Patent number: 10072272
    Abstract: The present invention provides a recombinant turkey herpesvirus modified by the presence of the cDNA encoding the hemagglutinin protein of avian influenza virus under a promoter. A poultry vaccine comprising the recombinant turkey herpesvirus described in the present invention can induce serological responses that may be easily detected by the hemagglutination inhibition assay but not by commercially available diagnostic ELISA kits; thus enabling easy differentiation between vaccination and field infection.
    Type: Grant
    Filed: November 24, 2014
    Date of Patent: September 11, 2018
    Assignee: BIOMUNE COMPANY
    Inventors: Motoyuki Esaki, Lauren Elizabeth Jensen, Kristi M. Dorsey
  • IBV strains and uses thereof
    Patent number: 9809802
    Abstract: The present invention relates to novel infectious bronchitis virus strains and the uses thereof. The invention particularly relates to an inactivated or attenuated IBV, as well as to vaccine compositions comprising the same and the uses thereof to vaccinate avians. The invention also relates to nucleic acids, infected cells and methods for detecting the infectious bronchitis virus strains of the invention in any sample.
    Type: Grant
    Filed: October 5, 2015
    Date of Patent: November 7, 2017
    Assignee: BIOMUNE COMPANY
    Inventors: Wil Solano, Brianna Ford, Chris Luther
  • Avian reoviridae and vaccines thereof
    Patent number: 9273287
    Abstract: This invention relates to novel unique strains avian reoviridae that were isolated from severe cases of Runting Stunting Syndrome. The present invention also relates to the isolation and uses of novel unique avian reoviridae, diagnostic assays using nucleotide or amino acid specific components of such viruses, such as the sequence encoding Sigma C capsid protein and to vaccines that protect birds from diseases caused by such viruses.
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: March 1, 2016
    Assignee: BIOMUNE COMPANY
    Inventors: Kristi Mae Dorsey, John Konx Rosenberger, Sandra Cloud Rosenberger
  • PRODUCTION OF AVIAN EMBRYO CELLS
    Publication number: 20140255447
    Abstract: The present invention relates to compositions and methods for preparing cells from avian embryos. The invention also relates to cultures of such cells and the uses thereof, particularly for producing viruses such as MDV. The invention also relates to methods for the preparation of vaccines using such cells or viruses.
    Type: Application
    Filed: March 5, 2013
    Publication date: September 11, 2014
    Applicant: BIOMUNE COMPANY
    Inventors: SHARAD DEVIDASRAO SAWARKAR, CHRISTOPHER PATRICK GULLY
  • Astrovirus
    Patent number: 8790657
    Abstract: This invention relates to the isolation and uses of novel avian astroviruses. The present invention also relates to vaccines, kits and methods for detection of a novel astrovirus. The present invention further relates to vaccination of avians, prevention and/or treatment of avian infections associated with astrovirus. Infections of poultry by this novel astrovirus are associated with runt stunting syndromes.
    Type: Grant
    Filed: June 26, 2009
    Date of Patent: July 29, 2014
    Assignee: Biomune Company
    Inventors: Kristi Mae Dorsey, John Knox Rosenberger, Sandra Cloud Rosenberger
  • NOVEL ASTROVIRUS
    Publication number: 20110171253
    Abstract: This invention relates to the isolation and uses of novel avian astroviruses. The present invention also relates to vaccines, kits and methods for detection of a novel astrovirus. The present invention further relates to vaccination of avians, prevention and/or treatment of avian infections associated with astrovirus. Infections of poultry by this novel astrovirus are associated with runt stunting syndromes.
    Type: Application
    Filed: June 26, 2009
    Publication date: July 14, 2011
    Applicant: BIOMUNE COMPANY
    Inventors: Kristi Mae Dorsey, John Knox Rosenberger, Sandra Cloud Rosenberger
  • UNIQUE AVIAN REOVIRIDAE
    Publication number: 20110150928
    Abstract: This invention relates to novel unique strains avian reoviridae that were isolated from severe cases of Runting Stunting Syndrome. The present invention also relates to the isolation and uses of novel unique avian reoviridae, diagnostic assays using nucleotide or amino acid specific components of such viruses, such as the sequence encoding Sigma C capsid protein and to vaccines that protect birds from diseases caused by such viruses.
    Type: Application
    Filed: June 26, 2009
    Publication date: June 23, 2011
    Applicant: BIOMUNE COMPANY
    Inventors: Kristi Mae Dorsey, John Knox Rosenberg, Sandra Cloud Rosenberger